Latest China News

Energy Fuels has amended its proposed acquisition of VAC after a customer dispute escalated into arbitration and lender forbearance at VAC’s US magnet plant. The filing also reveals VAC’s six-month net loss of €57.4 million, substantial debt and reliance on shareholder support ahead of the proposed transaction.

Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.

Rio Tinto’s third-quarter production update put its growth assets in the spotlight, with Oyu Tolgoi copper up 29% year to date and Simandou reaching a 10 Mtpa annualised run-rate. The miner maintained its 2026 production and unit-cost guidance while reporting more than US$2 billion of capital release arrangements.

Perpetual Resources and adviser GreenMet are assessing several US Government funding and financing pathways for the Nevada Scheelite tungsten project, as Washington prepares tighter defence sourcing rules. The interest is strategic, but no funding has been secured and the project remains without a Mineral Resource or Ore Reserve.

Fortescue shipped 46.8 million tonnes of iron ore in the September quarter, down 6% from a year earlier, while sales lagged production amid negotiations with China Mineral Resources Group. Net debt also rose to US$2.8 billion after the final dividend and quarterly capital spending, although FY27 guidance remains unchanged.

Renascor has produced battery-grade purified spherical graphite at demonstration scale, achieving 99.97% carbon purity through its hydrofluoric acid-free process. The result strengthens the commercialisation case, but Siviour graphite trials, customer qualification and project financing are still ahead.

Terrain Minerals has identified high-grade tungsten across six Smokebush prospects after re-assaying previously capped samples, with the strongest result reaching 0.75% WO₃. The company plans up to 12 tungsten-focused RC holes, although the mineralisation remains early-stage and only a third of the available samples has been tested.

AdAlta and Shanghai Cell Therapy Group have approved the FDA briefing pack and manufacturing transfer plan for EW-001, bringing the mesothelioma CAR-T therapy closer to an Australian Phase 1 trial. The FDA meeting is scheduled for November, while two Chinese patients remain under follow-up, including a second complete responder.

Aeris Environmental’s FY2026 annual report pairs international commercial progress with a $5.03 million operating cash drain, $9.22 million in net liabilities and an auditor-highlighted material uncertainty over its ability to continue as a going concern. The company says it will need extended related-party loan terms and further funding while converting its technology and chemicals pipeline into recurring revenue.

Lynas Rare Earths has agreed to acquire Meteoric Resources in an all-share deal valued at about A$968 million, adding the Caldeira rare earths project in Brazil to its portfolio. The proposed transaction would materially expand Lynas’ resource base, but still depends on shareholder, court and Brazilian regulatory approvals.

Oregon Group is seeking effective control of New Zealand King Salmon after agreeing to buy half of a 9.87% stake and secure voting rights over another holder’s shares. The proposed transaction would give Oregon control of 50.68% of NZK’s voting rights, subject to several approvals.

Cokal returned to coal sales at its BBM project during FY2026, but regulatory suspensions and weak cash generation pushed the company to a US$11.3 million loss and US$29.6 million of net liabilities. An auditor-highlighted material uncertainty over going concern remains, despite a post-year-end extension of major debt repayments.